S. Kirbas Et Al. , "Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease," ACTA CLINICA BELGICA , vol.71, no.2, pp.71-75, 2016
Kirbas, S. Et Al. 2016. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease. ACTA CLINICA BELGICA , vol.71, no.2 , 71-75.
Kirbas, S., Kirbas, A., Tufekci, A., Cure, M. C., Cakmak, S., Yazici, T., ... Cure, E.(2016). Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease. ACTA CLINICA BELGICA , vol.71, no.2, 71-75.
Kirbas, Serkan Et Al. "Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease," ACTA CLINICA BELGICA , vol.71, no.2, 71-75, 2016
Kirbas, Serkan Et Al. "Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease." ACTA CLINICA BELGICA , vol.71, no.2, pp.71-75, 2016
Kirbas, S. Et Al. (2016) . "Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease." ACTA CLINICA BELGICA , vol.71, no.2, pp.71-75.
@article{article, author={Serkan Kirbas Et Al. }, title={Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease}, journal={ACTA CLINICA BELGICA}, year=2016, pages={71-75} }